drugset / Trial / NCT07032688
A Clinical Study to Evaluate the Pharmacokinetic and Pharmacodynamics Properties of of SHR-3167 in Subjects With Type 2 Diabetes
NaSingle-groupOpen-labelTreatment
Summary
The objective of this study is to evaluate the pharmacokinetics and pharmacodynamics of SHR-3167 at steady state in subjects with type 2 diabetes.
Timeline
- Start
- 2025-08-11
- Primary completion
- 2027-03
- Completion
- 2027-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SHR-3167 | Unknown | — | — |
| Background | insulin degludec | Protein / enzyme biologic | — | — |